Abbvie reported $6.29B in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbott ABT:US $ 2982M 513M
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
AstraZeneca AZN:LN 1954M 415M
Biogen BIIB:US $ 814.2M 255M
Bristol Myers Squibb BMY:US $ 5289M 67M
Chemocentryx CCXI:US $ -22.31M 16.9M
Coherus Biosciences CHRS:US $ -38.53M 11.22M
Eisai 4523:JP Y 5564M 50219M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Endo International Ordinary Shares ENDP:US $ 220.65M 39.03M
Infinity Pharmaceuticals INFI:US $ -10.71M 0.56M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Johnson & Johnson JNJ:US $ 8058M 282M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Novartis NOVN:VX SF 4544M 120M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Revance Therapeutics RVNC:US $ -74.38M 2.18M
Teva Pharmaceutical Industries TEVA:US $ 807M 13M
Ultragenyx Pharmaceutical RARE:US $ -72.82M 49.15M
United Therapeutics UTHR:US $ 204.4M 12.1M
Zoetis ZTS:US $ 717M 11M